Hyderabad Telangana, India

Venkatesh Goura

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Suven Life Sciences Limited. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Venkatesh Goura. Retrieved from https://idiyas.com/inventor/venkatesh-goura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Venkatesh Goura: Innovator in Pharmaceutical Compounds

Introduction

Venkatesh Goura is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptors in the body.

Latest Patents

Venkatesh holds a patent for "Pyrrolo[1,2-b]-2-pyridazinone compounds as 5-HT4 receptor agonists." This invention relates to pyrrolo[1,2-b]-2-pyridazinone compounds of formula (I), or their isotopic forms, stereoisomers, or pharmaceutically acceptable salts thereof as 5-HT4 receptor agonists. The patent also describes methods of making such compounds, pharmaceutical compositions comprising these compounds, and their use in the treatment of gastrointestinal diseases or disorders. He has 1 patent to his name.

Career Highlights

Venkatesh is currently employed at Suven Life Sciences Limited, where he continues to work on innovative pharmaceutical solutions. His expertise in receptor agonists has positioned him as a valuable asset in the research and development sector.

Collaborations

He collaborates with talented professionals such as Ramakrishna Nirogi and Anil Karbhari Shinde, contributing to a dynamic team focused on advancing pharmaceutical research.

Conclusion

Venkatesh Goura's work in developing pyrrolo[1,2-b]-2-pyridazinone compounds showcases his commitment to innovation in the pharmaceutical industry. His contributions are paving the way for new treatments for gastrointestinal disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…